XML 89 R76.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Segment Reporting Information [Line Items]        
Dialysis and related lab patient service revenues $ 2,670,701 $ 2,561,543 $ 7,980,178 $ 7,478,938
Provision for uncollectible accounts (11,977) (119,321) (35,838) (335,979)
Net U.S. dialysis and related lab services patient service revenues 2,658,724 2,442,222 7,944,340 7,142,959
Other revenues 188,606 322,849 639,387 952,762
Total revenues 2,847,330 2,765,071 8,583,727 8,095,721
Operating income (loss) 289,038 395,294 1,137,916 1,662,418
Corporate administrative support (40,836) (10,965) (70,605) (32,587)
Debt expense (125,927) (109,306) (359,135) (321,637)
Other income, net 4,007 3,396 10,583 12,180
Income from continuing operations before income taxes 167,118 289,384 789,364 1,352,961
U.S. dialysis and related lab services        
Segment Reporting Information [Line Items]        
Total revenues 2,551,377 2,356,999 7,639,101 6,928,323
Other—Ancillary services and strategic initiatives        
Segment Reporting Information [Line Items]        
Total revenues 295,953 408,072 944,626 1,167,398
Operating Segments        
Segment Reporting Information [Line Items]        
Total revenues 2,881,115 2,784,542 8,675,418 8,152,768
Operating income (loss) 329,874 406,259 1,208,521 1,695,005
Operating Segments | U.S. dialysis and related lab services        
Segment Reporting Information [Line Items]        
Dialysis and related lab patient service revenues 2,584,769 2,483,644 7,725,187 7,285,962
Provision for uncollectible accounts (12,900) (117,962) (37,108) (334,031)
Net U.S. dialysis and related lab services patient service revenues 2,571,869 2,365,682 7,688,079 6,951,931
Other revenues 4,932 4,792 14,965 14,951
Total revenues 2,576,801 2,370,474 7,703,044 6,966,882
Operating income (loss) 390,006 442,777 1,272,828 1,837,989
Operating Segments | U.S. dialysis and related lab services | External Sources        
Segment Reporting Information [Line Items]        
Dialysis and related lab patient service revenues 2,559,345 2,470,169 7,661,244 7,247,403
Operating Segments | U.S. dialysis and related lab services | Intersubsegment Eliminations        
Segment Reporting Information [Line Items]        
Dialysis and related lab patient service revenues 25,424 13,475 63,943 38,559
Operating Segments | Other—Ancillary services and strategic initiatives        
Segment Reporting Information [Line Items]        
Dialysis and related lab patient service revenues 112,279 90,015 320,204 229,587
Other revenues 183,674 318,057 624,422 937,811
Total revenues 304,314 414,068 972,374 1,185,886
Operating income (loss) (60,132) (36,518) (64,307) (142,984)
Operating Segments | Other—Ancillary services and strategic initiatives | Intersubsegment Eliminations        
Segment Reporting Information [Line Items]        
Dialysis and related lab patient service revenues 8,361 5,996 27,748 18,488
Intersegment Elimination        
Segment Reporting Information [Line Items]        
Total revenues (33,785) (19,471) (91,691) (57,047)
Intersegment Elimination | U.S. dialysis and related lab services        
Segment Reporting Information [Line Items]        
Total revenues (25,424) (13,475) (63,943) (38,559)
Intersegment Elimination | Other—Ancillary services and strategic initiatives        
Segment Reporting Information [Line Items]        
Total revenues $ (8,361) $ (5,996) $ (27,748) $ (18,488)